Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Gynecologic Oncology|September 1, 1994
A comparison of intravenous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancerS Kirmani, P S Braly, E F McClay, et al.Investigational New Drugs|December 16, 1998
Phase I and pharmacokinetic study of intraperitoneal topotecanS C Plaxe, R D Christen, J O'Quigley, et al.Radiology|August 1, 1991
Endometrial thickness after menopause: effect of hormone replacementM C Lin, B B Gosink, S I Wolf, et al.Gynecologic Oncology|November 1, 1984
The subrenal capsule tumor implant assay as a predictor of clinical response to chemotherapy: 3 years of experienceJ A Stratton, P R Kucera, J P Micha, et al.Archives of Surgery (Chicago, Ill. : 1960)|November 1, 1985
Complications of pelvic exenterationJ G Jakowatz, D Porudominsky, D U Riihimaki, et al.Gynecologic Oncology|October 1, 1993
Phase I and pharmacokinetic study of intraperitoneal ormaplatinS C Plaxe, P S Braly, J L Freddo, et al.Gynecologic Oncology|November 1, 1986
Accurate laboratory predictions of the clinical response of patients with advanced ovarian cancer to treatment with cyclophosphamide, doxorubicin, and cisplatinJ A Stratton, P R Kucera, M A Rettenmaier, et al.British Journal of Cancer|November 15, 2007
A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimensC N Krasner, D S McMeekin, S Chan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group studyF M Muggia, P S Braly, M F Brady, et al.Pageof 3